Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
Crossref DOI link: https://doi.org/10.1007/s10096-016-2602-3
Published Online: 2016-02-15
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Palacios, R.
Pérez-Hernández, I. A.
Martínez, M. A.
Mayorga, M. L.
González-Domenech, C. M.
Omar, M.
Olalla, J.
Romero, A.
Romero, J. M.
Pérez-Camacho, I.
Hernández-Quero, J.
Santos, J.
Text and Data Mining valid from 2016-02-15